These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7922188)

  • 1. Kinins as vasoactive peptides.
    Fitzgibbon WR; Ploth DW; Margolius HS
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):283-90. PubMed ID: 7922188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinins and kinin receptors in the nervous system.
    Walker K; Perkins M; Dray A
    Neurochem Int; 1995 Jan; 26(1):1-16; discussion 17-26. PubMed ID: 7787759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological role of renal kallikrein-kinin system in human.
    Shimamoto K; Iimura O
    Adv Exp Med Biol; 1989; 247A():87-96. PubMed ID: 2557757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal kallikrein-kinin system].
    Nishimura K
    Nihon Rinsho; 1992 Dec; 50(12):2909-15. PubMed ID: 1337115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development biology of the renal kallikrein-kinin system.
    el-Dahr SS
    Pediatr Nephrol; 1994 Oct; 8(5):624-31. PubMed ID: 7819016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
    Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
    Pellacani A; Brunner HR; Nussberger J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S28-34. PubMed ID: 1282626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kininogen gene family in obstructive uropathy.
    El-Dahr SS
    Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin receptor ligands: therapeutic perspectives.
    Marceau F; Regoli D
    Nat Rev Drug Discov; 2004 Oct; 3(10):845-52. PubMed ID: 15459675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
    Nasjletti A; Colina-Chourio J; McGiff JC
    Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible effects of the kallikrein-kinin system on male reproductive functions.
    Schill WB; Miska W
    Andrologia; 1992; 24(2):69-75. PubMed ID: 1318646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal kallikrein-kinin system. Relation to renal function and blood pressure.
    Mayfield RK; Margolius HS
    Am J Nephrol; 1983; 3(2-3):145-55. PubMed ID: 6307046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A; Wolff HP
    Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins in the cardiovascular system.
    Schölkens BA
    Immunopharmacology; 1996 Jun; 33(1-3):209-16. PubMed ID: 8856152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kallikrein-kinin system, the kidney and arterial pressure].
    Alhenc-Gelas F; Baussant T; Gardes J; Corvol P
    Nephrologie; 1988; 9(1):3-7. PubMed ID: 2839786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
    Campbell DJ; Kladis A; Briscoe TA; Zhuo J
    Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin and related peptides in central control of the cardiovascular system.
    Diz DI
    Peptides; 1985; 6 Suppl 2():57-64. PubMed ID: 2867533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.